Skip to Content

Salofalk

In the US, Salofalk (mesalamine systemic) is a member of the drug class 5-aminosalicylates and is used to treat Crohn's Disease - Maintenance, Inflammatory Bowel Disease, Ulcerative Colitis, Ulcerative Colitis - Active, Ulcerative Colitis - Maintenance and Ulcerative Proctitis.

US matches:

UK matches:

Ingredient matches for Salofalk

Mesalazine

Mesalazine is reported as an ingredient of Salofalk in the following countries:

  • Argentina
  • Australia
  • Austria
  • Bosnia & Herzegowina
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Egypt
  • Estonia
  • Finland
  • Georgia
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Indonesia
  • Ireland
  • Latvia
  • Lebanon
  • Lithuania
  • Malaysia
  • Malta
  • Netherlands
  • Norway
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Thailand
  • Turkey
  • United Kingdom

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide